Abiopharma

🔍 Van Hauwermeiren Timothy (Executive)

Company: Lexeo Therapeutics, Inc. (LXEO)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 35,000 shares of Stock Option (right to buy) at $4.7 per share (Derivative)
  Date: 2026-06-25 | Code: A | Expires: 2036-06-24 | equity_swap_involved: 0 | shares_owned_after: 35,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: 100% of the shares underlying the option shall vest, and become exercisable, on the earlier of one year following the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continuous service on such date.